Back
Trevi Therapeutics, Inc. Stock Predictions
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
40
TRVI
Trevi Therapeutics, Inc.
Last Price:
$10.69
Seasonality Move:
91.5%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis NowTrevi Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 77.3% based on the past 6 years of stock performance.
-
Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Trevi Therapeutics, Inc. Stock Undervalued?The current Trevi Therapeutics, Inc. [TRVI] share price is $10.51. The Score for TRVI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
TRVI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Trevi Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 77.3% based on the past 6 years of stock performance.
Trevi Therapeutics, Inc. Stock Rating
Sell
40
Trevi Therapeutics, Inc. (TRVI)
is a Sell
Is Trevi Therapeutics, Inc. overpriced?
-
Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Trevi Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
trevitherapeutics.com
52-Week Data
52-Week High:
14.39
52-Week Low:
3.77
Prediction Charts
Market Cap:
1.3B
Price in USD:
10.51
Volume:
1.9M
Beta:
0.53
Technical Analysis
SMA50:
11.96
SMA100:
10.89
SMA200:
8.78
52-Wk Change:
166.08%
Stock Predictions
-
Is Trevi Therapeutics, Inc. stock public?Yes, Trevi Therapeutics, Inc. is a publicly traded company.
-
What is the Trevi Therapeutics, Inc. stock quote today?The Trevi Therapeutics, Inc. stock price is 10.51 USD today.
-
How to buy Trevi Therapeutics, Inc. stock online?You can buy Trevi Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-8 | 11.70 | 11.21 | 11.78 | 10.98 |
| Jan-9 | 11.31 | 11.18 | 11.64 | 11.12 |
| Jan-12 | 11.15 | 11.29 | 11.36 | 10.99 |
| Jan-13 | 11.31 | 11.29 | 11.59 | 11.13 |
| Jan-14 | 11.26 | 11.44 | 11.78 | 11.08 |
| Jan-15 | 11.39 | 10.76 | 11.75 | 10.61 |
| Jan-16 | 10.80 | 10.48 | 10.93 | 10.46 |
| Jan-20 | 10.27 | 10.42 | 10.62 | 10.19 |
| Jan-21 | 10.50 | 10.30 | 10.74 | 10.17 |
| Jan-22 | 10.30 | 10.94 | 11.15 | 10.29 |
| Jan-23 | 10.89 | 9.99 | 11.09 | 9.97 |
| Jan-26 | 9.91 | 10.15 | 10.30 | 9.88 |
| Jan-27 | 10.16 | 10.96 | 11.00 | 9.85 |
| Jan-28 | 10.94 | 10.51 | 11.10 | 10.24 |
Trevi Therapeutics, Inc. Earnings
Trevi Therapeutics, Inc. Earnings Report: Per Share Trevi Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Trevi Therapeutics, Inc. Forecast Revenue Growth
Trevi Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Trevi Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
* Trevi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.